The concept of oligometastatic disease in gastric cancer: reality or fiction?

Future Oncol. 2022 Jan;18(2):135-138. doi: 10.2217/fon-2021-1315. Epub 2021 Dec 10.

Abstract

Positive results in the RENAISSANCE Trial will establish oligometastatic gastric cancer as a real independent entity where total surgical treatment will become the standard of care.

Keywords: RENAISSANCE Trial; curative treatment; gastric cancer; local treatment; oligometastatic.

Publication types

  • Editorial

MeSH terms

  • Cytoreduction Surgical Procedures
  • Humans
  • Hyperthermic Intraperitoneal Chemotherapy
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / mortality
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / therapy
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / mortality
  • Lung Neoplasms / secondary*
  • Lung Neoplasms / therapy
  • Lymphatic Metastasis / diagnosis
  • Lymphatic Metastasis / pathology
  • Lymphatic Metastasis / therapy
  • Patient Selection
  • Peritoneal Neoplasms / diagnosis
  • Peritoneal Neoplasms / mortality
  • Peritoneal Neoplasms / secondary*
  • Peritoneal Neoplasms / therapy
  • Prognosis
  • Stomach Neoplasms / diagnosis
  • Stomach Neoplasms / mortality
  • Stomach Neoplasms / pathology*
  • Stomach Neoplasms / therapy
  • Survival Rate